Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of ISM5411 in adults with active ulcerative colitis
CTR20253800Phase 2Active
- Sponsor
- Insilico Medicine
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of garutadustat in autoimmune colitis, sponsored by Insilico Medicine. Started Dec 2025; status: active.
02
Drugs
garutadustat
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20253800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253800.